32 Cases of Meningitis in the Hoosier State

By Scott Sarvay
By Stephanie Parkinson
By Melissa Long
By Chris Darby

October 11, 2012 Updated Oct 17, 2012 at 5:48 PM EDT

Indiana (Indiana’s NewsCenter) - The number of meningitis cases in the Hoosier state has climbed again. The State Department of Health says 32 people are now ill with fungal meningitis, all associated with that tainted steroid commonly injected to treat back pain.

Those steroids went to hospitals and pain clinics in just six Indiana communities including right here in Fort Wayne.

Officials with Fort Wayne Physical Medicine said they received vials of the medicine but they sat on a shelf and were not administered to any patients.

The exposure list has been lowered in the Hoosier state. It was at 1,577 but is now listed at 1,568.

Around the nation several people have died from the illness. Indiana's death toll remains at two.

A state health official confirmed Sunday morning, that the number of cases of fungal meningitis is up to eight. That's three more then the reported five cases on Saturday. No deaths have been reported in the state.

Seven people are dead across the country and more than 60 people in nine states have contracted the virus.

"Fort Wayne Physical Medicine" says it did receive a lot of the tainted steriod which has been linked to several cases of meningitis but no patients were injected with the medication.

Other sites across the state the FDA says received this tainted shot are Ambulatory Care Center, LLP in Evansville, OSMC Outpatient Surgery Center in Elkhart, South Bend Clinic in South Bend, Union Hospital in Terre Haute and Wellspring in Columbus.

560 patients in Evansville have received the injections and ten of those patients are reporting symptoms.

The FDA says the patients received the steroid shots for back pain. The drug was given out in 23 states.

What are your thoughts CLICK HERE to leave us a "QUESTION OF THE DAY” comment.

© Copyright 2016, A Quincy Media broadcasting station. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

To submit a comment on this article, your email address is required. We respect your privacy and your email will not be visible to others nor will it be added to any email lists.